Bought
~$4.6K256 sh @ $17.91
Traded Oct 6, 2025 · filed 9 days later
A 10% owner of Spruce Biosciences paid $4.6K out of pocket for Spruce Biosciences shares.
Loading…
SPRB · NASDAQ · Pharmaceutical Preparations
Pharmaceutical Preparations company based in South San Francisco, Ca.
In the last 90 days, no insider of Spruce Biosciences reported an open-market purchase and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Revenue
—
Year earlier: $0
Free cash flow, last 12 months
−$22.3M
This quarter −$22.3M, a year earlier −$8.83M
Net cash
$76.4M
Debt $19.9M, cash $96.3M, at Jun 30, 2026
Net income, last 12 months
−$51.4M
Operating profit covers interest -26.6x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 12, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$0
−100.0% vs the year before
Net income, fiscal 2025
−$39M
A loss for the year
Shares outstanding
2.87M
As of Aug 10, 2026
Traded Oct 6, 2025 · filed 9 days later
A 10% owner of Spruce Biosciences paid $4.6K out of pocket for Spruce Biosciences shares.
Traded Oct 6, 2025 · largest single transaction ~$4.5KNot under a reported trading plan
Oct 6, 2025~$4.5K · 232 sh @ $19.33
DetailsOfficial recordOct 6, 2025~$436 · 25 sh @ $17.46
DetailsOfficial recordTraded Oct 6, 2025 · filed 3 days later
A 10% owner of Spruce Biosciences paid $4.6K out of pocket for Spruce Biosciences shares. The Spruce Biosciences shares held grew by 24%.
Traded Oct 6, 2025 · filed 3 days laterNot under a reported trading plan
A 10% owner of Spruce Biosciences sold $4.5K of Spruce Biosciences shares. The filing does not indicate a pre-arranged trading plan.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.